Abstract

In the last two decades, a dramatic shift in the paradigm of management of type 2 diabetes has been settled. Reduction of diabetic complications became the primary target instead of focusing on the mere glycemic control. The tight blood sugar control among type 1 (T1DM) and type 2 (T2DM) diabetes mellitus patients aimed at avoidance of long-term complications of diabetes. In spite of the significant impact of this approach on the incidence of these complications, the outcome is still not satisfactory. The frequent failure to achieve tight blood sugar control and the lack of hypoglycemic agents that are capable to combat the underlying pathogenic mechanisms of diabetic complications underlie this unsatisfactory outcome. These drawbacks are overcome in the newly introduced hypoglycemic agents. In this review, we are going to discuss these mechanisms and highlight the therapeutic value of the early use of these agents instead of the long-standing traditional approach.

How to Cite
M. SALEM, USAMA AA SHARAF EL DIN, DINA O ABDULAZIM, Mona. Should we Change our Therapeutic Management of Type 2 Diabetes based on Accumulating Evidence?. Global Journal of Medical Research, [S.l.], july 2019. ISSN 2249-4618. Available at: <https://medicalresearchjournal.org/index.php/GJMR/article/view/1796>. Date accessed: 21 aug. 2019.

Organize Conference

We organize seminars /symposium /conferences/workshop/webinar worldwide on innovative topics and fields of Computer Science and research. We also collaborate, partner or sponsor with a view to provide our professional guidance and expertise to conduct in standard way.

Read More

Research Membership

Global Journals Inc., as described in our Corporate Statement, is an educational, research, research publishing, and professional membership organization. Elevation to the ranks of Fellow of the Association of the Research Society in Computer and Member of the Association of the Research Society in Computer is open.

Read More